NYSE:CLB - Core Laboratories Stock Price, Price Target & More

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Core Laboratories announced a quarterly dividend on Friday, July 13th. Investors of record on Monday, July 23rd will be paid a dividend of $0.55 per share on Monday, August 13th. This represents a $2.20 annualized dividend and a dividend yield of 1.91%. The ex-dividend date of this dividend is Friday, July 20th. View Core Laboratories' Dividend History.

Core Laboratories (NYSE:CLB) released its quarterly earnings results on Wednesday, April, 25th. The oil and gas company reported $0.57 earnings per share (EPS) for the quarter, hitting the Zacks' consensus estimate of $0.57. The oil and gas company earned $170 million during the quarter, compared to analyst estimates of $171.03 million. Core Laboratories had a return on equity of 62.69% and a net margin of 13.24%. The company's revenue was up 8.6% on a year-over-year basis. During the same period in the prior year, the company posted $0.42 EPS. View Core Laboratories' Earnings History.

Core Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Core Laboratories.

Core Laboratories issued an update on its third quarter earnings guidance on Monday, July, 2nd. The company provided earnings per share guidance of $0.64-0.66 for the period, compared to the Thomson Reuters consensus estimate of $0.74. The company issued revenue guidance of $177-179 million, compared to the consensus revenue estimate of $187.06 million.Core Laboratories also updated its Q2 guidance to $0.57-0.59 EPS.

11 analysts have issued twelve-month target prices for Core Laboratories' shares. Their predictions range from $96.00 to $136.00. On average, they expect Core Laboratories' stock price to reach $113.9940 in the next year. This suggests that the stock has a possible downside of 0.9%. View Analyst Ratings for Core Laboratories.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 2 sell ratings, 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to Core Laboratories include Subsea 7 (SUBCY), RPC (RES), Oceaneering International (OII), Liberty Oilfield Services (LBRT), Franks International (FI), SemGroup (SEMG), Mammoth Energy Services (TUSK), Select Energy Services (WTTR), C&J Energy Services (CJ), Superior Energy Services (SPN), Keane Group (FRAC), FTS International (FTSI), Helix Energy Solutions Group (HLX), Hurricane Energy (HRCXF) and NCS Multistage (NCSM).

Headlines about CLB stock have trended positive recently, Accern Sentiment reports. Accern ranks the sentiment of press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Core Laboratories earned a coverage optimism score of 0.32 on Accern's scale. They also gave media coverage about the oil and gas company an impact score of 47.11 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

Core Laboratories' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Fisher Asset Management LLC (1.02%), Manning & Napier Group LLC (0.19%), Franklin Street Advisors Inc. NC (0.18%), Gofen & Glossberg LLC IL (0.13%), Bank of Montreal Can (0.10%) and Forte Capital LLC ADV (0.04%). Company insiders that own Core Laboratories stock include Martha Z Carnes and Michael Straughen. View Institutional Ownership Trends for Core Laboratories.

CLB stock was sold by a variety of institutional investors in the last quarter, including Municipal Employees Retirement System of Michigan. View Insider Buying and Selling for Core Laboratories.

CLB stock was purchased by a variety of institutional investors in the last quarter, including Manning & Napier Group LLC, Bank of Montreal Can, Fisher Asset Management LLC, Forte Capital LLC ADV, First Citizens Bank & Trust Co., World Asset Management Inc, Franklin Street Advisors Inc. NC and Gofen & Glossberg LLC IL. Company insiders that have bought Core Laboratories stock in the last two years include Martha Z Carnes and Michael Straughen. View Insider Buying and Selling for Core Laboratories.

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CLB stock can currently be purchased for approximately $114.98.

Core Laboratories has a market capitalization of $5.08 billion and generates $659.81 million in revenue each year. The oil and gas company earns $83.12 million in net income (profit) each year or $2.00 on an earnings per share basis. Core Laboratories employs 4,600 workers across the globe.

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]